AzTrials
AzTrials

Anorexia NervosaNCT05056597

Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa

An observational study of Anorexia Nervosa and Bulimia Nervosa, run by University of California, San Diego at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to investigate areas of the brain responsible for 'liking', 'wanting', and learning in adults with eating disorders using brain imaging techniques, computer tasks, a test meal, and self-report questionnaires and interviews. Read more about this study

Who is it for?
Ages 18 to 39 years, women onlyHealthy volunteers can take part
Conditions the study is for
Anorexia Nervosa, Bulimia Nervosa
How many people
252 participants
Where
1 siteUnited States
Study dates
26 May 2022to Jan 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 39 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: The study will recruit 189 adult women currently ill with ED including anorexia nervosa, restricting type (AN-R, n=63), AN binge eating/purging type (AN-BP, n=63), and bulimia nervosa (BN, n=63) and 63 healthy control (HC) women between the ages of 18 and 39.

Who may be able to join

  • Eating Disorder Group:
  • Between the ages of 18 and 39 years old
  • Meet DSM-V criteria for AN-R, AN-BP, or BN
  • Healthy Control Group:
  • Between the ages of 18 and 39 years old
  • Have maintained 85% to 120% ideal body weight since menarche

Who cannot join

  • All Groups:
  • Psychotic illness/other mental illness requiring hospitalization
  • Current dependence on drugs or alcohol defined by DSM IV criteria. Additionally, positive test results for drug use on the day of the scan, apart of marijuana, will result in cancelling or rescheduling the scan because acute use will impact MRI measures.
  • Physical conditions (e.g. diabetes mellitus, pregnancy) known to influence eating or weight
  • Neurological disorder, neurodevelopmental disorder, or history of head injury with >30 min loss of consciousness
  • Any contraindication to undergoing an MRI
Show all 13Show fewer
  • Primary obsessive compulsive disorder or primary major depressive disorder
  • Additional Exclusion Criteria for ED Group:
  • -If taking other psychotropic medication, any change in dosage in the 2 weeks before scanning
  • Additional Exclusion Criteria for Healthy Control Group:
  • Meet criteria for the diagnosis of any psychiatric disorder currently
  • Any history of binge eating or purging behaviors, including self-induced vomiting, laxative or diuretic misuse
  • Use of any psychoactive or other medication known to affect mood or concentration in the last 3 months

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Christina Wierenga contact

858-534-8047

cwierenga@health.ucsd.edu

United States1 site, 1 recruiting
  • UCSD Eating Disorders Treatment and Research Program

    La Jolla, California, 92121

    Megan Martinho, 858-210-0318, mamartinho@health.ucsd.edu

    Katherine Gandee, 858-534-0371, kgandee@health.ucsd.edu

    Recruiting

Other trials in United States

About this study

The purpose of this study is to investigate areas of the brain responsible for 'liking', 'wanting', and learning in adults with eating disorders using brain imaging techniques, computer tasks, a test meal, and self-report questionnaires and interviews. The investigators will study changes in brain activity using a procedure called functional magnetic resonance imaging (fMRI). This study will include 252 women with an eating disorder (63 AN-restricting type (AN-R), 63 AN-binge eating/purging type (AN-BP), 63 bulimia nervosa (BN)) and 63 healthy controls (HC) aged 18-39.

Aim 1: To examine neural differences in 'liking' and 'wanting' in ED relative to HC.

Read more

Aim 2: To examine differences in instrumental learning for reward and punishment in ED relative to HC.

Aim 3: To examine how 'liking' and 'wanting' drive instrumental learning in ED and predict clinical symptoms at baseline and 1 year later.

Exploratory Aim: To explore the associations of dopamine function, as measured by neuromelanin MRI (NM-MRI), with ED diagnosis and brain response to 'liking', 'wanting', and learning.

Medical subject headings
Anorexia Nervosa, Bulimia Nervosa

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05056597
Study groupRoleWhat they receive
AN-RParticipants that meet Diagnostic And Statistical Manual Of Mental Disorders (DSM-V) criteria for Anorexia Nervosa restricting subtype.
AN-BPParticipants that meet DSM-V criteria for Anorexia Nervosa binging/purging subtype
BNParticipants that meet DSM-V criteria for Bulimia Nervosa.
Healthy ControlsParticipants that do not meet DSM-V criteria for any disorder.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. BOLD response

    Brain activity associated with 'liking', 'wanting', and learning

    Measured: 1 Year

  2. Reward and Punishment Learning

    Task reinforcement learning rate in reward and punishment trials

    Measured: 1 Year

  3. Connectome-based predictive modeling (CPM)

    Functional connectivity maps from task-based fMRI data and clinical data

    Measured: 1 Year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Sep 2021
  2. Study start26 May 2022
  3. Primary completionJan 2027 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
252 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05056597
Sponsor's protocol ID
800775
Status last verified
Apr 2026
First submitted
9 Sep 2021
Last updated
28 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Anorexia Nervosa and Bulimia Nervosa, run by University of California, San Diego at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Christina Wierenga (858-534-8047, cwierenga@health.ucsd.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

BOLD response (time frame: 1 Year). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in